224 related articles for article (PubMed ID: 22379930)
1. [Intracrinology and dehydroepiandrosterone--a new perspective for the use of androgens in hormone replacement therapy in postmenopausal women].
Perzyło K; Kulik-Rechberger B; Gałczyński K; Rechberger T
Ginekol Pol; 2011 Sep; 82(9):690-5. PubMed ID: 22379930
[TBL] [Abstract][Full Text] [Related]
2. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology.
Labrie F; Luu-The V; Labrie C; Simard J
Front Neuroendocrinol; 2001 Jul; 22(3):185-212. PubMed ID: 11456468
[TBL] [Abstract][Full Text] [Related]
3. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone.
Labrie F; Luu-The V; Labrie C; Bélanger A; Simard J; Lin SX; Pelletier G
Endocr Rev; 2003 Apr; 24(2):152-82. PubMed ID: 12700178
[TBL] [Abstract][Full Text] [Related]
4. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
Labrie F
J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731
[TBL] [Abstract][Full Text] [Related]
5. Science of intracrinology in postmenopausal women.
Labrie F; Bélanger A; Pelletier G; Martel C; Archer DF; Utian WH
Menopause; 2017 Jun; 24(6):702-712. PubMed ID: 28098598
[TBL] [Abstract][Full Text] [Related]
6. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.
Labrie F; Bélanger A; Luu-The V; Labrie C; Simard J; Cusan L; Gomez JL; Candas B
Steroids; 1998; 63(5-6):322-8. PubMed ID: 9618795
[TBL] [Abstract][Full Text] [Related]
7. DHEA, important source of sex steroids in men and even more in women.
Labrie F
Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
[TBL] [Abstract][Full Text] [Related]
8. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
9. DHEA and intracrinology at menopause, a positive choice for evolution of the human species.
Labrie F; Labrie C
Climacteric; 2013 Apr; 16(2):205-13. PubMed ID: 23126249
[TBL] [Abstract][Full Text] [Related]
10. Adrenal androgens and intracrinology.
Labrie F
Semin Reprod Med; 2004 Nov; 22(4):299-309. PubMed ID: 15635498
[TBL] [Abstract][Full Text] [Related]
11. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.
Labrie F; Diamond P; Cusan L; Gomez JL; Bélanger A; Candas B
J Clin Endocrinol Metab; 1997 Oct; 82(10):3498-505. PubMed ID: 9329392
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
[TBL] [Abstract][Full Text] [Related]
13. Is dehydroepiandrosterone a hormone?
Labrie F; Luu-The V; Bélanger A; Lin SX; Simard J; Pelletier G; Labrie C
J Endocrinol; 2005 Nov; 187(2):169-96. PubMed ID: 16293766
[TBL] [Abstract][Full Text] [Related]
14. Is DHEA replacement beneficial in chronic adrenal failure?
Lang K; Burger-Stritt S; Hahner S
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):25-32. PubMed ID: 25617170
[TBL] [Abstract][Full Text] [Related]
15. DHEA replacement for postmenopausal women: placebo or panacea?
Eden JA
Climacteric; 2015; 18(4):439-40. PubMed ID: 25731680
[TBL] [Abstract][Full Text] [Related]
16. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
17. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology.
Labrie F; Martel C; Bélanger A; Pelletier G
J Steroid Biochem Mol Biol; 2017 Apr; 168():9-18. PubMed ID: 28153489
[TBL] [Abstract][Full Text] [Related]
18. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women.
Labrie F; Bélanger A; Labrie C; Candas B; Cusan L; Gomez JL
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):57-69. PubMed ID: 17627814
[TBL] [Abstract][Full Text] [Related]
20. Extragonadal synthesis of sex steroids: intracrinology.
Labrie F
Ann Endocrinol (Paris); 2003 Apr; 64(2):95-107. PubMed ID: 12773942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
